European Patent Office

T 0323/05 (Finasteride/MERCK) vom 09.08.2007

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2007:T032305.20070809
Datum der Entscheidung
9. August 2007
Aktenzeichen
T 0323/05
Antrag auf Überprüfung von
-
Anmeldenummer
93203163.6
IPC-Klasse
C07J 73/00
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden und -mitglieder verteilt (B)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
A process for the production of finasteride
Name des Antragstellers
Merck & Co., Inc.
Name des Einsprechenden
Gedeon Richter Ltd.
Kammer
3.3.01
Leitsatz
-
Schlagwörter
Adaptation of the description after a decision to maintain the patent in amended form - consistent with the amended set of claims (yes)
Orientierungssatz
Rule 57a EPC establishes a limit to the amendments which can be made to the patent in suit, namely the amendments must be occasioned by grounds of opposition specified in Article 100 EPC, even if the respective ground has not been invoked by the opponent.
Article 84 and Rule 57a EPC are the two provisions which must guide the Proprietor of the patent when he is invited by the Opposition Division to adapt the description. In other words, the amendments must be appropriate and necessary, and nothing more (see point 3 of the reasons).

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance with the order to maintain the patent on the basis of the claims as ordered by the Board in its decision of 16 September 2003, page 2 of the description as maintained by the decision of the Opposition Division dated 27 January 2005 and page 3 of the description as in the main request filed on 4 July 2007.